Physician profile
Joyce Danter
NPI 1992737480
$10,137.09
in general payments reported to CMS, 2019-2025
47 companies · $1,396 in 2025
The $1,396 reported for 2025 was more than what 89% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,251 · 2022: $2,145 · 2023: $2,452 · 2024: $1,892 · 2025: $1,396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,738 · Education: $2.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,738.36 |
| Education | $2.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,485.87 | 2021-2025 | |
| Novo Nordisk INC | $920.52 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $807.96 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $680.13 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Bausch Health US, LLC | $678.06 | 2021-2025 | Aplenzin, Wellbutrin |
| Kowa Pharmaceuticals America, INC. | $667.56 | 2021-2023 | Livalo, Seglentis |
| Amarin Pharma, INC. | $461.86 | 2021-2023 | |
| Amneal Pharmaceuticals LLC | $407.54 | 2021-2025 | Unithroid |
| Amgen INC. | $379.43 | 2021-2025 | Repatha, Otezla, Repatha |
| Corium, LLC | $331.03 | 2022-2025 | Azstarys |
| Noven Therapeutics, LLC | $305.82 | 2023-2025 | Secuado, Xelstrym |
| Pfizer INC. | $290.19 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $248.17 | 2021-2024 | Trintellix |
| Idorsia Pharmaceuticals US INC | $241.74 | 2022-2025 | Quviviq, Quviviq |
| Merck Sharp & Dohme LLC | $235.89 | 2021-2023 | Belsomra, Steglatro |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joyce Danter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.